News LivaNova PLC

Equities

LIVN

GB00BYMT0J19

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
55.53 ^USD	+0.78%		+6.12%	+7.33%

Mar. 20	Sector Update: Health Care Stocks Ease Late Afternoon	MT
Mar. 20	Sector Update: Health Care Stocks Down Wednesday Afternoon	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LivaNova : 2023 UK Annual Report	Apr. 26	PU
LivaNova : 2024 Proxy Statement and Notice of Annual General Meeting	Apr. 26	PU
LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident	Apr. 25	BU
LivaNova to Announce First-Quarter 2024 Results	Mar. 21	BU
Sector Update: Health Care Stocks Ease Late Afternoon	Mar. 20	MT
Sector Update: Health Care Stocks Down Wednesday Afternoon	Mar. 20	MT
LivaNova Says Sleep Apnea Study Likely to Meet Primary Efficacy Endpoint; Shares Jump	Mar. 20	MT
LivaNova Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	Mar. 20	BU
LivaNova PLC Announces a Positive Predictive Outcome of Trial Success in its OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea	Mar. 20	CI
Transcript : LivaNova PLC Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-12-2024 10:45 AM	Mar. 12
LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029	Mar. 05	BU
LivaNova Proposes $300 Million Private Placement of Notes	Mar. 04	MT
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior Notes	Mar. 04	BU
LivaNova to Present at the Barclays Global Healthcare Conference	Mar. 04	BU
Barclays Adjusts Price Target on LivaNova to $61 From $57, Keeps Equalweight Rating	Feb. 27	MT
Barclays Raises Price Target on LivaNova to $61 From $57, Maintains Equalweight Rating	Feb. 26	MT
Wolfe Research Adjusts LivaNova's Price Target to $65 From $58, Keeps Outperform Rating	Feb. 22	MT
Baird Adjusts LivaNova's Price Target to $62 From $56, Keeps Neutral Rating	Feb. 22	MT
Mizuho Securities Adjusts Price Target on LivaNova to $75 From $70, Maintains Buy Rating	Feb. 22	MT
Needham Adjusts Price Target on LivaNova to $72 From $62, Keeps Buy Rating	Feb. 21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News LivaNova PLC

Equities

LIVN

GB00BYMT0J19

Summary

Filters